Lisata to use Haystack’s MRD tests for pancreatic cancer therapy trial
Lisata Therapeutics has partnered with Haystack Oncology, a Quest Diagnostics company, to use the latter’s minimal residual disease (MRD) test…
Lisata Therapeutics has partnered with Haystack Oncology, a Quest Diagnostics company, to use the latter’s minimal residual disease (MRD) test…
XyloCor Therapeutics has signed a licencing agreement with SmartWise, a subunit of SmartCella Holding, to use the latter’s Extroducer infusion…
Tectonic Therapeutic has completed a reverse merger with Avrobio and will begin trading on the Nasdaq global market as Tectonic…
AstraZeneca has committed to $80m in non-dilutive funding to Swiss biotech SixPeak Bio, which is developing a bispecific antibody therapy…
AiM Medical Robotics has partnered with Harvard Medical School’s affiliate Brigham and Women's Hospital (BWH) to conduct a study validating…
NeuroSense is partnering with Boston-based company PhaseV, which specialises in using causal machine learning (ML) for clinical trial analysis and…
Australian healthcare technology and services company Resonance Health has agreed to acquire 100% of clinical research centre TrialsWest for a…
US-based Seyltx has closed an agreement to acquire Algernon Pharmaceuticals’ chronic cough therapy, ifenprodil (NP-120). Algernon received a purchase price…
PCM Trials has acquired US-based EmVenio Research, a community-based clinical trial site provider equipped with mobile research units, to design…
Eli Lilly continues to make news by announcing its complete acquisition of the Massachusetts-headquartered Sigilon on 14 August. The deal…